Cite

HARVARD Citation

    Melo-Lima, S. et al. (n.d.). Bcl-xL modulates cell survival and drug resistance in edelfosine-treated glioblastoma cells. European journal of cancer. pp. S62-. [Online]. 
  
Back to record